Gateway Foundation continually strives to the best treatment center in the country. We work day in and day out to provide the most effective and compassionate care to those individuals suffering from substance use disorders and mental health conditions.

We also do everything we can to provide support and communication to family members, loved ones, and professionals that support those in treatment.

To this end, we invest in our staff, our clinical programs, and our facilities each year to get better and better, in increasing the effectiveness of the treatment and overall Gateway experience. We are proud of our amazing staff and the quality of care that we deliver. We are also proud when our efforts are recognized by outside organizations. Below is a list of current awards, recognitions and accomplishments.

  • NALGAP
  • LegitScript
  • National Association of Addiction Treatment Providers
  • Joint Commission International for Quality Approval
  • Substance Abuse and Mental Health Services Administration
  • Top 3 Addition Treatment Centers in Chicago
  • Best Addition Treatment Centers in Newsweek
  • Top performer in LGBTQ Healthcare Equality
NALGAP logo
Legitscript.com monitored certificate
National Association of Addiction Treatment Providers logo
Joint commission international quality approval certificate
SAMHSA logo
Certificate for the top 3 addiction treatment centers in Chicago in 2020
Best addiction treatment centers of 2020 certificate
Healthcare quality index top performer

Chicago Addiction Treatment Program Meets Top, Dual Diagnosis Rating Gateway Foundation ASPIRE Program Officially Provides Enhanced Services For Patients Battling Co-Occurring Substance Use and Mental Health Disorders
CHICAGO — Illinois-based Gateway Foundation (gatewayfoundation.org) announces that its female-only ASPIRE program meets the benchmark of a Dual Diagnosis Enhanced (DDE) site. This benchmark means that ASPIRE has the official capability to accommodate individuals with acute and unstable mental health disorders along with substance use disorders.

A group of family and friends holding hands

Gateway’s ASPIRE program is the first program of those evaluated by The Illinois Co-occurring Center for Excellence (ICOCE) to meet this benchmark.

“Research indicates that 80 percent of individuals with substance use issues also struggle with mental health issues, like depression and anxiety. Obtaining DDE means Gateway staff has the skills and tools needed to help those we serve achieve long-term success,” says Thomas Britton, Gateway Foundation CEO.

DDE is an American Society of Addiction Medicine (ASAM) Patient Placement Criteria (PPC-2R) category. This specific rating comes from the Dual Diagnosis Capability in Addiction Treatment index (DDCAT), established through Dartmouth Medical School. The DDCAT is a valid and reliable benchmark to measure the capability of addiction treatment programs to provide services to individuals with co-occurring disorders.

Britton adds, “I’m proud to lead a team that’s always seeking new ways to provide next-level care. DDE proves we serve Illinois in a way that can and will transform the lives of many.”

The DDCAT index was created in 2003 in response to the increased number of patients facing co-occurring mental health disorders in addiction treatment settings. At least thirty states utilize these index measures to critically evaluate programs on policy, clinical practice, and workforce. Thirty-five specific categories are evaluated with three possible outcomes: Addiction Only Services (AOS), Dual Diagnosis Capable (DDC), and DDE.

“DDE means ASPIRE is the multifaceted, well-rounded program for women we built it to be,” says Gilbert Lichstein, Clinical Director at Gateway. “This independent validation shows our clients that Gateway is the right choice for treatment.” Dr. Britton adds “We will continue to elevate treatment for the growing number of Illinois residents who need substance use disorder and mental health treatment.”

The six-year old Gateway ASPIRE program provides treatment for women suffering from substance use disorders and co-occurring mental health conditions. ICOCE, established through a grant from the State of Illinois’ Department of Human Services, Division of Alcohol and Substance Abuse (IDHS/DASA), conducted the DDCAT review of ASPIRE. Funding for ICOCE services, which include DDCAT reviews, training and education, technical assistance, and consultation, is funded in whole or in part by IDHS/DASA. IDHS/DASA is the state agency responsible for licensing and oversight of all Illinois’ substance use disorder treatment centers. IDHS/DASA also serves as subject matter experts and provides leadership on best practices, along with the Division of Mental Health.